BRD2 and ovarian carcinoma: (49) reported that gonadotropin treatment (FSH or LH) reduced GnRH2 expression in the majority of ovarian cancer cell lines tested (including OVCAR-3 cells); however, GnRH1 mRNA was unaffected by treatment (49).